- Home
- BBAR vs PTGX Comparison
BBAR vs PTGX Comparison
Compare BBAR & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBAR
- PTGX
- Stock Information
- Founded
- BBAR 1886
- PTGX 2006
- Country
- BBAR Argentina
- PTGX United States
- Employees
- BBAR N/A
- PTGX N/A
- Industry
- BBAR Commercial Banks
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- BBAR Finance
- PTGX Health Care
- Exchange
- BBAR Nasdaq
- PTGX Nasdaq
- Market Cap
- BBAR 1.9B
- PTGX 4.0B
- IPO Year
- BBAR N/A
- PTGX 2016
- Fundamental
- Price
- BBAR $16.40
- PTGX $79.21
- Analyst Decision
- BBAR Strong Buy
- PTGX Strong Buy
- Analyst Count
- BBAR 2
- PTGX 9
- Target Price
- BBAR $22.00
- PTGX $78.11
- AVG Volume (30 Days)
- BBAR 1.9M
- PTGX 1.6M
- Earning Date
- BBAR 11-25-2025
- PTGX 10-31-2025
- Dividend Yield
- BBAR 0.49%
- PTGX N/A
- EPS Growth
- BBAR N/A
- PTGX N/A
- EPS
- BBAR 0.38
- PTGX 0.80
- Revenue
- BBAR $1,945,235,030.00
- PTGX $209,180,000.00
- Revenue This Year
- BBAR N/A
- PTGX N/A
- Revenue Next Year
- BBAR $12.16
- PTGX $140.23
- P/E Ratio
- BBAR $15.59
- PTGX $99.17
- Revenue Growth
- BBAR N/A
- PTGX N/A
- 52 Week Low
- BBAR $7.76
- PTGX $33.31
- 52 Week High
- BBAR $25.01
- PTGX $93.25
- Technical
- Relative Strength Index (RSI)
- BBAR 72.57
- PTGX 60.22
- Support Level
- BBAR $16.30
- PTGX $75.44
- Resistance Level
- BBAR $17.37
- PTGX $80.43
- Average True Range (ATR)
- BBAR 1.02
- PTGX 2.48
- MACD
- BBAR 0.60
- PTGX -0.36
- Stochastic Oscillator
- BBAR 81.79
- PTGX 74.63
About BBAR Banco BBVA Argentina S.A. ADS
Banco BBVA Argentina SA is a banking services provider in Argentina. It provides financial assistance to large corporations, small and medium-sized companies, as well as individuals. It bank provides services through retail, corporate, investment banking, and Small and medium-sized companies divisions. Through the retail banking segment, it provides banking products and services to individuals, corporate banking deals with services to corporates, and the small and medium-sized companies segment focuses on foreign trade, agricultural business, and digital products.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.